CovAngelo Accurately Models Reaction Barriers for Covalent Drug Discovery

BEIT has developed CovAngelo, a new method for modeling chemical reaction barriers in drug discovery that addresses a critical limitation of existing workflows. Traditional docking methods determine if a molecule fits within a protein, but fail to predict whether a covalent bond will actually form, a question dependent on an extremely sensitive “activation barrier,” where even a few kcal/mol difference can completely reorder which compounds look promising. CovAngelo departs from conventional approaches by dividing the drug discovery system into layers, each treated at the level of theory it actually requires, employing a layered quantum mechanical/molecular mechanics approach. This innovation allows for more accurate modeling of the subtle electronic effects and surrounding environment crucial to predicting successful covalent inhibitors, potentially reducing costly experimental failures.

Covalent Drug Design Challenges with Traditional Methods Traditional drug discovery excels at determining if a molecule can physically fit within a protein’s active site and interact favorably, but this approach falls short when designing covalent inhibitors, which require a second, more complex assessment: will a chemical bond actually form? This crucial distinction stems from the need to accurately calculate the activation barrier, the energetic hurdle a reaction must overcome, a parameter notoriously difficult to predict with precision. Most existing computational methods either oversimplify this barrier calculation or avoid it altogether, relying on scoring functions never intended to account for bond formation or quantum chemistry methods hampered by computational demands, particularly within complex protein environments. As a result, research teams frequently pursue compounds that appear promising in simulations only to encounter experimental failure, highlighting a significant gap between prediction and reality. This disconnect arises because even minor inaccuracies in modeling the system can dramatically alter predicted activity, underscoring the need for more robust and reliable methods. CovAngelo begins with classical molecular mechanics to define the protein’s overall structure and long-range interactions, then introduces quantum-mechanical descriptions near the active site to capture polarization effects and the behavior of surrounding molecules, culminating in high-accuracy quantum chemistry focused on the bond-forming event itself. This allows for realistic modeling of biological systems while resolving the fine electronic details governing reactivity, a combination critical for accurate prediction and efficient drug design. QM/QM/MM Approach & ECC-DMET Embedding Strategy The pursuit of increasingly precise molecular modeling has led researchers to combine multiple quantum mechanical (QM) and molecular mechanics (MM) methods, a strategy now refined by BEIT with their CovAngelo platform. CovAngelo differs from this by employing a layered approach, treating different parts of a drug discovery system at the appropriate level of theoretical rigor. This innovation centers on a QM/QM/MM methodology, where the protein and solvent are initially modeled using classical mechanics to establish broad structural features. To overcome the computational demands of such detailed modeling, CovAngelo utilizes an embedding strategy based on ECC-DMET, isolating the chemically active region and representing the environment in a computationally efficient manner. Further enhancing efficiency, the platform incorporates quantum-information-optimized (QIO) orbitals, selected based on their participation in the chemistry, dramatically reducing the number of required calculations while maintaining accuracy. Quantum-Information-Optimized Orbitals Enhance Computational Efficiency BEIT is addressing a critical bottleneck in drug discovery by focusing on the computational demands of modeling covalent bond formation, a process increasingly vital for developing targeted therapies. “Small errors in how we model the system can lead to large errors in predicted activity,” highlighting the sensitivity of these calculations and the potential for misleading results. Instead of attempting to apply a single theoretical method to the entire system, CovAngelo divides the molecular environment into regions treated with varying levels of complexity. Crucially, the bond-forming event itself receives the highest level of quantum chemical treatment. This QM/QM/MM methodology is further enhanced by quantum-information-optimized (QIO) orbitals, which streamline calculations. These orbitals are selected based on how strongly they participate in the chemistry, rather than relying purely on chemical intuition, resulting in a more compact and efficient representation of the problem. This optimization is essential because high-accuracy quantum chemistry calculations are notoriously computationally expensive, especially when applied to large biological systems. The platform also incorporates molecular dynamics sampling and explicit solvent modeling, acknowledging that proteins are dynamic and water plays a critical role in many covalent mechanisms. By combining these techniques, BEIT aims to provide a more realistic and reliable picture of the underlying chemistry, ultimately improving the success rate of covalent drug discovery programs and enabling the development of more effective therapies. At the end of the day, drug discovery is shaped by physics. The more faithfully we model it, the better our decisions become. CovAngelo Validated on BTK-Zanubrutinib Michael Addition The pursuit of covalent drugs, offering targeted and clinically effective therapies, demands increasingly precise modeling of chemical reactions; current computational methods, however, often fall short in accurately predicting whether a bond will actually form between a drug candidate and its protein target. Unlike most existing methods that either oversimplify the barrier calculation or avoid it altogether, CovAngelo utilizes a QM/QM/MM methodology, beginning with classical molecular mechanics to describe the protein and solvent at a large scale. Closer to the active site, a quantum-mechanical description captures polarization effects, recognizing that the local environment often stabilizes or destabilizes the transition state in ways that simpler models miss. The core of the reaction itself receives the highest accuracy quantum chemistry treatment, focusing computational effort where it matters most. To validate this approach, researchers examined the covalent inhibition of Bruton’s tyrosine kinase (BTK) by zanubrutinib, a clinically relevant targeted covalent inhibitor undergoing a Michael addition. The study demonstrated that differing levels of theoretical treatment can yield significantly different activation barriers, while CovAngelo’s embedded, high-accuracy approach produced results more consistent with expected physical behavior within a realistic protein environment. This consistency is critical, as reaction energetics directly influence which compounds progress in drug discovery; CovAngelo isn’t merely a theoretical framework, but a computational platform designed for integration into modern workflows, and is designed with fault-tolerant quantum computing (FTQC) in mind from the start. Source: https://beit.tech/blog/covangelo-bringing-real-chemistry-back-into-covalent-drug-discovery Tags: